These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8729161

  • 1. Serum lipid and lipoprotein metabolism after glucose ingestion in NIDDM and IGT patients. Apolipoprotein-containing particles.
    Nagai T, Tomizawa T, Minamide S, Nakajima K, Mori M.
    Diabetes Care; 1996 Apr; 19(4):365-8. PubMed ID: 8729161
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impaired glucose tolerance without hypertriglyceridemia does not enhance postprandial lipemia.
    Higashi K, Shige H, Ito T, Nakajima K, Ishikawa T, Nakamura H, Ohsuzu F.
    Horm Metab Res; 2001 Feb; 33(2):101-5. PubMed ID: 11294490
    [Abstract] [Full Text] [Related]

  • 7. Remnant-like particles (RLP) from NIDDM patients with apolipoprotein E3/3 phenotype stimulate cholesteryl ester synthesis in human monocyte-derived macrophages.
    Saito M, Eto M, Okada M, Iwashima Y, Makino I.
    Artery; 1996 Feb; 22(3):155-63. PubMed ID: 8893973
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adiponectin is independently associated with apolipoprotein B to A-1 ratio in Koreans.
    Park JS, Cho MH, Nam JS, Yoo JS, Lee YB, Roh JM, Ahn CW, Jee SH, Cha BS, Lee EJ, Lim SK, Kim KR, Lee HC.
    Metabolism; 2010 May; 59(5):677-82. PubMed ID: 19914667
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect?
    Bourn DM, Mann JI, McSkimming BJ, Waldron MA, Wishart JD.
    Diabetes Care; 1994 Nov; 17(11):1311-9. PubMed ID: 7821173
    [Abstract] [Full Text] [Related]

  • 16. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I.
    Diabetes Care; 1995 May; 18(5):646-53. PubMed ID: 8586002
    [Abstract] [Full Text] [Related]

  • 17. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB, Fitzsimons O, Moreno S, Owens D, Collins P, Johnson A, Tomkin GH.
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
    Pietzsch J, Julius U, Nitzsche S, Hanefeld M.
    Diabetes; 1998 Dec; 47(12):1928-34. PubMed ID: 9836526
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.